title: PEG-IFN-alpha-2a therapy in patients with myelofibrosis: a study of the French Groupe d'Etudes des Myelofibroses (GEM) and France Intergroupe des syndromes Myéloprolifératifs (FIM).
authors: Jean-Christophe
authors: JC
authors: Ianotto
authors: Jean-Jacques
authors: JJ
authors: Kiladjian
authors: Jean-Louis
authors: JL
authors: Demory
authors: Lydia
authors: L
authors: Roy
authors: Françoise
authors: F
authors: Boyer
authors: Jerôme
authors: J
authors: Rey
authors: Brigitte
authors: B
authors: Dupriez
authors: Christian
authors: C
authors: Berthou
authors: Jean-François
authors: JF
authors: Abgrall
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006401:Hematologic Agents / Q000627:therapeutic use*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D011994:Recombinant Proteins
chemical_list: D006401:Hematologic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a